Run time: 57m

  3      0

2020 AABB Annual Meeting On-Demand

AM20-06: Cellular Therapies for SARS-CoV2


Oct 3, 2020 11:15am ‐ Oct 3, 2020 12:15pm


Expiration Date: Dec 31, 2022


Credits: None available.

Standard: $25.00
Members: $20.00

Description

Join us as we review the latest cellular therapy advancements for treatment in the COVID-19 pandemic. In addition to addressing the use of specific T cells in COVID-19 treatment, faculty will also discuss the importance of missing imputation for single cell sequencing (MISC) in COVID-19 analysis.

Learning Objectives:
  • Discuss the latest cellular therapies advancements in the COVID-19 pandemic
  • Investigate the use of specific T cells in COVID-19 treatment
  • Discuss the importance of missing imputation for single cell sequencing (MISC) in COVID-19 analysis

Speaker(s):

Disclosures

  • Dusan Bogunovic : Nothing to disclose
  • Michael Keller : Consultant: Gilead

Credits Available


AM20-06: Cellular Therapies for SARS-CoV2 Evaluation

You must be logged in and own this session in order to post comments.